Canada Markets closed

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6404-0.5246 (-45.03%)
At close: 04:00PM EDT
0.6285 -0.01 (-1.04%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.1650
Open0.7050
Bid0.6222 x 800
Ask0.6264 x 1300
Day's Range0.6100 - 0.7050
52 Week Range0.6100 - 55.6000
Volume50,194,344
Avg. Volume7,121,662
Market Cap77.742M
Beta (5Y Monthly)1.11
PE Ratio (TTM)N/A
EPS (TTM)-0.7740
Earnings DateMay 02, 2022 - May 06, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est100.00
  • GlobeNewswire

    Agile Therapeutics Announces Pricing of $24 Million Upsized Public Offering

    PRINCETON, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the pricing of its upsized public offering of an aggregate of 26,666,666 shares of its common stock (or pre-funded warrants in lieu thereof), together with accompanying common stock warrants, at a public offering price of $0.90 per share (or pre-funded warrant) and accompanying warrants. Each share of common stock (or pr

  • GlobeNewswire

    Healthcare Breakthroughs: KZR, NMLSF, AGRX, LMLLF Report Latest Advances in Novel Therapeutics for Inflammatory Diseases, Oncology, and Autism

    NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Kezar Life Sciences (NASDAQ: KZR), Nova Mentis Life Sciences (OTC: NMLSF), Agile Therapeutics (NASDAQ: AGRX), and PharmaDrug (OTC: LMLLF) (CSE: PHRX). As the global pharma market surpasses $1.3 trillion dollars (Statista), emerging technologies and healthcare research innovations are unleashing new exponential gr

  • GlobeNewswire

    Agile Therapeutics to Present at The H.C. Wainwright Global Investment Conference

    PRINCETON, N.J., May 17, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced that Al Altomari, Chairman and Chief Executive Officer, will present at the H.C. Wainwright Global Investment Conference taking place May 23-May 26, 2022 in Miami, FL. Details on the Company presentation are as follows: Event:H.C. Wainwright Global Investment ConferenceDate:Tuesday, May 24, 2022Time:10:00-10:30 am ET The H.C. Wainwright Global Investment Conference w